Detalles de la búsqueda
1.
Occult lymph node metastases in patients without residual muscle-invasive bladder cancer at radical cystectomy with or without neoadjuvant chemotherapy: a nationwide study of 5417 patients.
World J Urol
; 40(1): 111-118, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34585294
2.
European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.
J Eur Acad Dermatol Venereol
; 35(9): 1750-1764, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34245180
3.
European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.
J Eur Acad Dermatol Venereol
; 35(10): 1926-1948, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34309078
4.
Prediction of early (30-day) and late (30-90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades.
World J Urol
; 38(9): 2197-2205, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31728672
5.
Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer.
Int J Cancer
; 144(6): 1453-1459, 2019 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30155893
6.
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.
World J Urol
; 37(1): 165-172, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29882105
7.
Short-term outcome after cystectomy: comparison of early oral feeding in an enhanced recovery protocol and feeding using Bengmark nasojejunal tube.
World J Urol
; 36(2): 221-229, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29167985
8.
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.
World J Urol
; 36(11): 1775-1781, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171454
9.
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought.
World J Urol
; 36(10): 1621-1627, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29721611
10.
Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment.
Ann Oncol
; 27(7): 1311-6, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27091807
11.
Deck-chair sign: unreserved.
Clin Exp Dermatol
; 46(3): 560-561, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32970866
12.
Birch pollen sensitization with cross-reactivity to food allergens predominates in adults with eosinophilic esophagitis.
Allergy
; 68(11): 1475-81, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24351068
13.
Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival.
World J Urol
; 31(5): 1297-302, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22875170
14.
Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial.
Front Oncol
; 13: 1246603, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37711193
15.
Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes.
J Urol
; 187(2): 446-50, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22177147
16.
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients.
Actas Urol Esp (Engl Ed)
; 45(6): 473-478, 2021.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-34147426
17.
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium.
Eur Urol Focus
; 7(6): 1347-1354, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32771446
18.
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer.
Sci Rep
; 10(1): 10952, 2020 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32616859
19.
[Not Available]. / Le Fibroblast Growth Factor Receptor 3 (FGFR3), cible thérapeutique pour le traitement personnalisé du cancer de la vessie : validation anatomo-pathologique du concept.
Prog Urol
; 24(13): 806-7, 2014 Nov.
Artículo
en Francés
| MEDLINE | ID: mdl-26461579
20.
Incidence of eosinophilic esophagitis in the Netherlands continues to rise: 20-year results from a nationwide pathology database.
Neurogastroenterol Motil
; 30(1)2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28745828